Evaluating Serum Sex Steroid Hormones
Reproducibility of Serum Sex Steroid Measurement: A Proof of Performance Study
2 other identifiers
observational
60
1 country
1
Brief Summary
The purpose of this study is to evaluate the reproducibility of measurements of sex hormone levels in serum samples. Researchers will collect blood from 60 healthy adults, including 20 men, 20 premenopausal women, and 20 postmenopausal women. Blood samples will be collected after study participants have fasted overnight.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Aug 2003
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 6, 2003
CompletedFirst Submitted
Initial submission to the registry
June 19, 2006
CompletedFirst Posted
Study publicly available on registry
June 21, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
February 25, 2011
CompletedJuly 2, 2017
February 25, 2011
June 19, 2006
June 30, 2017
Conditions
Keywords
Eligibility Criteria
You may qualify if:
- We plan to recruit healthy men aged 50-65 from Westat employees and family and friends of Westat employees.
- One month later we will recruit 20 pre menopausal women (aged 20-40) and 20 post menopausal women (aged 55-75).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Cancer Institute (NCI), 9000 Rockville Pike
Bethesda, Maryland, 20892, United States
Study Design
- Study Type
- observational
- Sponsor Type
- NIH
Study Record Dates
First Submitted
June 19, 2006
First Posted
June 21, 2006
Study Start
August 6, 2003
Study Completion
February 25, 2011
Last Updated
July 2, 2017
Record last verified: 2011-02-25